Understanding the link between interleukin 17 and vaccine-induced protection in tuberculosis

Understanding the link between interleukin 17 and vaccine-induced protection in tuberculosis

<p>Tuberculosis (TB), caused by infection with <em>Mycobacterium tuberculosis (M.tb)</em>, remains a global health problem and although BCG offers some protection against childhood disseminated disease and other mycobacterial infections, its efficacy against pulmonary TB varies bet...

Descrizione completa

Dettagli Bibliografici
Autore principale:	Griffiths, K
Altri autori:	McShane, H
Natura:	Tesi
Lingua:	English
Pubblicazione:	2012
Soggetti:	Immunology Medical Sciences Vaccinology Infectious diseases Biology

Documenti analoghi

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
di: Ronan, E
Pubblicazione: (2011)

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
di: Hennig, B, et al.
Pubblicazione: (2008)

Innate immune responses to tuberculosis vaccines
di: Matsumiya, M
Pubblicazione: (2014)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
di: Harris, S, et al.
Pubblicazione: (2013)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
di: Antrobus, R
Pubblicazione: (2014)

HIV-specific interleukin-10 responses and immune modulation
di: Clutton, G
Pubblicazione: (2012)

A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods
di: Warrell, M, et al.
Pubblicazione: (2008)

Long term efficacy of a pre-erythrocytic malaria vaccine and correlates of protection in children residing in a malaria endemic country
di: Olotu, A
Pubblicazione: (2013)

Innate immune pathways controlling IL-1beta production and adjuvant-induced T helper 17 cell differentiation
di: Shenderov, K
Pubblicazione: (2011)

B cell responses to conjugate and polysaccharide meningococcal vaccines
di: Ramasamy, M
Pubblicazione: (2012)

Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
di: Bauza, K
Pubblicazione: (2012)

Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers
di: Ahmed, T, et al.
Pubblicazione: (2014)

Evaluation of the immunological mechanisms induced by mycobacteria and the potential effect this may have on immunity induced by tuberculosis vaccines
di: Poyntz, HC
Pubblicazione: (2012)

Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
di: Elias, SC
Pubblicazione: (2014)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
di: Matsumiya, M, et al.
Pubblicazione: (2014)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
di: Alharbi, N
Pubblicazione: (2014)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations
di: Hanekom, W, et al.
Pubblicazione: (2008)

Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
di: Pinpathomrat, N
Pubblicazione: (2018)

Development of antimalarial human monoclonal antibodies against Plasmodium falciparum
di: Wang, LT
Pubblicazione: (2022)

Evaluation of immune correlates to TB vaccines
di: Marsay, L
Pubblicazione: (2011)

Control of typhoid fever: evaluating herd protection through public health use of typhoid VI polysaccharide vaccine
di: Ochiai, R
Pubblicazione: (2011)

B cell response to pneumococcal vaccines
di: Trück, J
Pubblicazione: (2014)

A systems biology approach to define SARS-CoV-2 correlates of protection in non-human primates
di: Brady, C
Pubblicazione: (2024)

The design and development of an HIV-1 vaccine to elicit a broadly neutralising antibody response
di: Wan, L, et al.
Pubblicazione: (2012)

Towards a universally effective HLA-E-targeted HIV vaccine - a structural and biophysical exploration
di: Walters, L
Pubblicazione: (2019)

Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
di: de Cassan, S
Pubblicazione: (2011)

Genetics determinants of vaccine responses
di: O'Connor, D
Pubblicazione: (2014)

Evaluation of a potential vaccine against hyperinvasive serogroup B Neisseria meningitidis by assessment of the effects of surface-expressed Opacity-associated proteins on the immune system
di: Sadarangani, M
Pubblicazione: (2011)

The role of lung tissue-resident memory T cells in protection against tuberculosis
di: Bull, N
Pubblicazione: (2017)

T cell responses in Kenyan infants: impact on HIV-1 evolution during infection and an assessment of vaccine-induced memory responses in HIV-exposed uninfected infants
di: Garcia Knight, M
Pubblicazione: (2014)

Developing novel blood-stage malaria vaccines
di: Douglas, AD
Pubblicazione: (2015)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
di: Kapulu, MC
Pubblicazione: (2014)

Transcutaneous delivery of T Cell-inducing viral vector Malaria vaccines by microneedle patches
di: Pearson, FE
Pubblicazione: (2011)

Biodegradable pulsatile release technologies for viral vector based vaccinations
di: Krastev, C
Pubblicazione: (2018)

Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial
di: Diggle, L, et al.
Pubblicazione: (2006)

T-cell receptor (TCR) usage in HIV-2 infection
di: Moysi, E
Pubblicazione: (2012)

Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins
di: Lee, Y, et al.
Pubblicazione: (2006)

Novel adenoviral vectored vaccines and the implications of viral diversity in therapeutic strategies against Hepatitis C Virus infection
di: Kelly, C
Pubblicazione: (2013)

The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM197 conjugate vaccine
di: Clutterbuck, E, et al.
Pubblicazione: (2006)

Refocusing antibody responses by chemical modification of vaccine antigens
di: Schiffner, T
Pubblicazione: (2014)